First Trust Capital Management’s Select Medical SEM Stock Holding History

First Trust Capital Management’s Portfolio SEM Stock Details SEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-105,446	Closed	-$1.72M	–	185
2026 Q1	$1.72M	Buy	+105,446	New	+$1.65M	0.09%	150

Other funds holding SEM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

DAM

Decagon Asset Management London, United Kingdom $525M AUM 50.51% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

First Trust Capital Management's SEM Position: Q2 2026 in Review

First Trust Capital Management sold out of Select Medical (SEM) in Q2 2026, closing a stake of 105,446 shares — an estimated $1.72M sold.

First Trust Capital Management first reported a position in SEM in Q1 2026 and held it in 1 quarter. The position peaked at $1.72M in Q1 2026. 238 funds tracked by Wall St. Rank hold SEM as of Q2 2026.

First Trust Capital Management reported no remaining Select Medical position as of Q2 2026 after selling out during the quarter.
First Trust Capital Management sold 105,446 Select Medical shares in Q2 2026, an estimated $1.72M.
First Trust Capital Management first reported a position in Select Medical in Q1 2026 and held it in 1 quarter.
First Trust Capital Management's Select Medical position peaked at $1.72M in Q1 2026.
238 funds tracked by Wall St. Rank held Select Medical as of Q2 2026.

Based on First Trust Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.